Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Breath analysis enables prediction of atherosclerotic cardiovascular disease risk.

The American journal of the medical sciences·2026
Same author

Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer's disease pathology and systemic bone loss.

Journal of neuroinflammation·2026
Same author

Association of mitochondrial genome variants with Alzheimer's disease in a Chinese population.

Journal of Alzheimer's disease : JAD·2026
Same author

Apolipoprotein E4 and synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic implications.

Ageing research reviews·2026
Same author

Multidimensional modeling of biological aging: integrating gait, eye movement, rest-state functional connectivity, and plasma biomarkers in non-dementia older adults.

The journal of prevention of Alzheimer's disease·2026
Same author

VMD-LSTM based water level prediction of aquifer in mining working face.

Scientific reports·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Shilin Luo1, Hui Liu1, Tingting Xiao1

  • 1Xiangya Hospital, Central South University, Changsha, Hunan, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

血PPPP2R5C显示为早期阿尔茨海默病 (AD) 诊断的新型生物标志物具有前途. 这种蛋白质的蛋白质.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 遗传学 遗传学 是一个

背景情况:

  • 早期干预对于管理阿尔茨海默病 (AD) 至关重要.
  • 确定可靠的早期诊断生物标志物对于有效的AD干预至关重要.
  • 目前的诊断方法可能无法捕捉AD病理的早期阶段.

研究的目的:

  • 在神经元衍生外体 (NDEs) 中识别新型蛋白质生物标志物,用于早期AD检测.
  • 在更大的患者队伍中验证已识别的生物标志物的诊断潜力.
  • 阐明一个关键生物标志物的机械作用在AD的发病.

主要方法:

  • 从家族性AD (FAD),FAD前和认知正常 (CN) 个体中对NDE的蛋白质组学分析.
  • 在零星的AD和轻度认知障碍 (aMCI) 队列中使用向质谱和酶相关免疫吸收试验 (ELISA) 进行验证.
  • 在体外和体内研究,以调查PPPP2R5C在AD病理中的机制,包括与Tau和自途径的相互作用.

主要成果:

  • 在NDE和血中通过AD进展观察到PPPP2R5C蛋白的水平降低 (FAD < pre-FAD < CN和AD < aMCI < CN).
  • 血PPPP2R5C显示了AD (AUC=0.84) 和aMCI (AUC=0.74) 的显著诊断准确性.
  • PPP2R5C与Tau相互作用,降低其总和酸化水平,并通过ULK1.1影响自.

结论:

  • 血PPPP2R5C是一种潜在的新生物标志物,用于早期诊断阿尔茨海默病.
  • PPP2R5C在AD病变发生过程中发挥作用,可能是通过Tau相互作用和自的调节.
  • 对PPP2R5C的进一步研究可能会导致改善AD的早期诊断策略.